資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

頁面路徑選單

Joint Reconstruction Devices Market Analysis By Technique (Joint Replacement, Osteotomy, Arthroscopy, Resurfacing, Arthrodesis, Implants, Bone Graft), By Joint Type (Knee, Hip, Shoulder, Ankle), & Segment Forecasts, 2014 - 2025

  • LinkedIn
  • facebook
  • Twitter
出版日期:2017/05/02
頁  數:90頁
文件格式:PDF
價  格:
USD 4,950 (Single-User License)
USD 7,950 (Multi-User License)
USD 9,950 (Global-User License)
線上訂購或諮詢
The global joint reconstruction devices market is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc. High adoption of minimally invasive surgeries across the globe has given rise to technological advancement in surgical devices and procedures. In addition, growing prevalence of joint-related conditions and changing therapeutic approaches are expected to boost the market growth.
The joint reconstruction devices market is largely dependent on technological development. Ongoing studies on improving robotically-assisted surgeries and bionic implants are expected to play a pivotal role in the development of total joint replacement surgeries market. These advancements are expected to help in complex surgeries to improve success rate of these procedures and increase patient convenience.
A major share of the joint reconstruction market is captured by large joints. Knee and hip joint reconstruction together captured more than half of the revenue share in 2016. The prevalence of conditions related to these two joints is higher as compared to other joints due to overuse. Treatment of conditions related to these joints is crucial to recover the mobility of patients. Thus, a significant amount of funds are invested in R&D of large joint reconstruction techniques.
Further key findings from the report suggest:
‧ Joint replacement techniques captured the largest share in 2016 and is expected to maintain dominance throughout the forecast period. High procedural volume and high price of implants are anticipated to drive growth.
‧ Development of operating techniques, allografts, and synthetic bone grafts are expected to boost growth of the bone graft segment. The segment is further divided into allograft and synthetic sub-segments.
‧ The knee segment is expected to dominate the market throughout the forecast period. Availability of a large number of treatment options and introduction of innovative surgical techniques are expected to drive the growth of the segment.
‧ Developing economies, increased foreign direct investment, rising demand, and emergence of local players are factors that are expected to render fastest growth in the Asia Pacific region.
‧ Key players of the market include Medtronic; Nuvasive, Inc.; Zimmer Biomet; Stryker; DePuy Synthes; Aesculap Implant Systems, LLC; Smith and Nephew; CONMED Corporation; and DJO Global, Inc.
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Approaches for Market Estimation
1.3.1 Approach 1: Demand Analysis& Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market segmentation& Scope
Chapter 3 Joint Reconstruction Market Variables, Trends & Scope
3.1 Market Segmentation& Scope
3.1.1 Market driver analysis
3.1.2 Market restraint analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Joint Reconstruction - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Joint Reconstruction Market: Technique Estimates & Trend Analysis
4.1 Joint Reconstruction Market: Technique Movement Analysis
4.2 Joint Replacement
4.2.1 Joint replacement market estimates and forecast, 2014 - 2025 (USD Million)
4.2.2 Implants
4.2.2.1 Implants market estimates and forecast, 2014 - 2025 (USD Million)
4.2.3 Bone graft
4.2.3.1 Bone graft market estimates and forecast, 2014 - 2025 (USD Million)
4.2.3.2 Allograft
4.2.3.2.1 Allograft market estimates and forecast, 2014 - 2025 (USD Million)
4.2.3.3 Synthetic
4.2.3.3.1 Synthetic market estimates and forecast, 2014 - 2025 (USD Million)
4.3 Osteotomy
4.3.1 Osteotomy market estimates and forecast, 2014 - 2025 (USD Million)
4.4 Arthroscopy
4.4.1 Arthroscopy market estimates and forecast, 2014 - 2025 (USD Million)
4.5 Resurfacing
4.5.1 Resurfacing market estimates and forecast, 2014 - 2025 (USD Million)
4.6 Arthrodesis
4.6.1 Arthrodesis market estimates and forecast, 2014 - 2025 (USD Million)
4.7 Others
4.7.1 Others market estimates and forecast, 2014 - 2025 (USD Million)
Chapter 5 Joint Reconstruction Market: Joint Type Estimates & Trend Analysis
5.1 Joint Reconstruction Market: Joint Type Movement Analysis
5.2 Knee
5.2.1 Knee market estimates and forecast, 2014 - 2025 (USD Million)
5.3 Hip
5.3.1 Hip market estimates and forecast, 2014 - 2025 (USD Million)
5.4 Shoulder
5.4.1 Shoulder market estimates and forecast, 2014 - 2025 (USD Million)
5.5 Ankle
5.5.1 Ankle market estimates and forecast, 2014 - 2025 (USD Million)
5.6 Others
5.6.1 Others market estimates and forecast, 2014 - 2025 (USD Million)
Chapter 6 Joint Reconstruction Market: Regional Estimates & Trend Analysis, By Technique, and Joint Type
6.1 Joint Reconstruction: Region Movement Analysis
6.2 North America
6.2.1 North America joint reconstruction market estimates and forecast, 2014 - 2024 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Canada joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Europe joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Germany joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.4.2 China
6.4.2.1 China joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.4.3 India
6.4.3.1 India joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.6 Middle East and Africa (MEA)
6.6.1 MEA joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa joint reconstruction market estimates and forecast, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Covidien plc
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Stryker Corporation
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Zimmer Biomet
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Depuy Synthes
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Smith and Nephew
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Aesculap Implant Systems, LLC
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Conmed Corporation
7.3.7.1 Company overview
7.3.7.1 Financial performance
7.3.7.2 Product benchmarking
7.3.7.3 Strategic initiatives
7.3.8 Donjoy Inc.
7.3.8.1 Company overview
7.3.8.2 Product benchmarking
7.3.8.3 Strategic initiatives
7.3.9 Nuvasive, Inc
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Wright Medical Technology Inc
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives

回上頁